The objective of the present study was to determine the effects of inhibition of mevalonate biosynthesis on fertility and embryonic survival in laying chickens. White Leghorn hens were fed for 5 weeks with a control diet alone or a diet supplemented with one of two concentrations (0.03 or 0.06%) of the 3-hydroxy-3-methylglutaryl\x=req-\ coenzyme A reductase inhibitors atorvastatin, lovastatin or simvastatin. The hens were artificially inseminated once a week and eggs that were not analysed for cholesterol content were incubated. When averaged across dietary groups and expressed as a percentage of all eggs incubated, the incidence of unfertilized eggs was 1.6% (controls), 29 Hargis, 1988) . The inability to decrease egg cholesterol content markedly through genetic selection programmes led Hargis (1988) (Griffin, 1992) . Moreover Cocchi, 1990; Griffin, 1992 
Introduction
The cholesterol concentration of avian eggs varies among species, breeds and strains, and also with the age of birds. However, genetic selection for lower egg cholesterol content has been unsuccessful or has resulted in only slight reductions (approximately 10 mg per egg; for review see Hargis, 1988) . The inability to decrease egg cholesterol content markedly through genetic selection programmes led Hargis (1988) to hypothesize that chickens have a physiological control mechanism that causes a cessation of egg production when yolk cholesterol deposition is inadequate for embryonic survival. On the basis of this hypothesis, nutritional or pharmacological manipulation of cholesterol biosynthesis in laying hens would not be expected to cause a significant decrease in cholesterol in the yolk of non-fertilized eggs because egg production would cease when the 'critical concentration' was reached.
However, there is little evidence to support this hypothesis (Griffin, 1992) . Moreover, it has been suggested, on the basis of lipid metabolism studies in avian embryos, that the amount of cholesterol provided by the yolk is considerably greater than the needs of the developing chick (Noble and Cocchi, 1990; Griffin, 1992) .
Recent work from this laboratory with inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGR) also failed to support the 'critical concentration hypothesis' and cast doubt upon the presence of a cholesterol-sensing mechanism that is directly linked with reproductive function. When laying hens were administered orally with the HMGR inhibitors lovastatin (Elkin and Rogler, 1990) or PD 123244-15 (Elkin et ah, 1993) , there were 15 and 30% decreases in egg cholesterol, respectively, and less effect on egg production (no change or -18%, respectively). HMGR is the rate-limiting enzyme in cholesterol synthesis and catalyses the conversion of 3-hydroxy-3-methylglutarylcoenzyme A to mevalonate (Endo, 1992) . HMGR inhibitors are currently the most effective and widely used class of cholesterol-lowering drugs available for the treatment of hypercholesterolaemia in humans (Endo, 1992;  Dujovne, 1997 (Elkin et ah, 1999 (Elkin and Rogler, 1990) containing 0.06% avicel® microcrystalline cellulose (FMC Corp., Philadelphia, PA) (diet 1), while five hens each were fed the same ration supplemented, at the expense of avicel®, with 0.03% atorvastatin (diet 2), 0.06% atorvastatin (diet 3), 0.03% lovastatin (diet 4), 0.06% lovastatin (diet 5), 0.03% simvastatin (diet 6), or 0.06% simvastatin (diet 7). The two concentrations of inhibitor were equal to approximately 30 or 60 mg per hen per day, respectively, on the basis of a food intake of 100 g per bird per day (Elkin and Rogler, 1990) . Atorvastatin was synthesized and provided by Parke-Davis (Roth et ah, 1991 
Statistical analysis
The percentage of fertilized eggs, hatched eggs and dead embryos, as well as chick body weights and egg cholesterol contents, were subjected to analysis of variance using a nested factorial arrangement of treatments (Steel and Torrie, 1980) . Since incubation conditions were the same each week, a split plot in time (week) was also included in the analysis, which was performed using the general linear models procedure of the SAS® Institute (1989) . Arcsin transfor¬ mations were also performed on all percentage data.
However, since the statistical patterns were similar for both transformed and untransformed results, only the latter are presented. Individual treatment differences were tested by Duncan's multiple range test (Steel and Torrie, 1980) . Single degree of freedom linear contrasts (Steel and Torrie, 1980) were also performed to make comparisons between the HMGR inhibitors and to compare them with the control treatment. Differences at < 0.05 were considered significant. The curve fitter procedure of SlideWrite® Plus Version 3 for Windows™ (Advanced Graphics Software, Inc., Carlsbad, CA), which applies linear least squares regression analysis, was used to determine the relationship between hatchability per week of all eggs incubated and egg cholesterol values.
Results

Fertility
Although semen characteristics were not determined in the pooled samples used to artificially inseminate the hens, the overall fertility rate of 98.4% in the control hens indicates that sperm quantity and quality were consistently high (Fig. la) . In contrast, when averaged over the 5 week study, the percentage of fertilized eggs was significantly reduced, in a concentration-dependent manner, in the atorvastatin hatchability of fertilized eggs, (c) hatchability of total eggs incubated.
The total number of eggs incubated from control hens (n = 10) and (Fig. 2) Embryonic death in the 0.03% and 0.06% atorvastatin groups, which had the lowest hatch rates (Fig. lc) (Dostal et ah, 1996) .
In spite of an association between hatchability and egg cholesterol content, there was tremendous variability in the hatchability rate of eggs that contained approximately 105 mg cholesterol (0.06% atorvastatin treatment, weeks 2-5). This indicates that egg cholesterol content is not the only factor that influences embryonic survival. Moreover, the present work challenged the hypothesis (Hargis, 1988) (Noble and Cocchi, 1990; Griffin, 1992) , on the basis of lipid metabolism studies, that egg yolk cholesterol may be more of an excess waste product than an essential component required by embryonic tissues.
In addition to failure of fertilization, embryonic mortality is the other major factor that affects the hatchability rate of eggs. Although mortality was slightly higher in embryos from HMGR inhibitor-fed hens compared with controls, the differences were not significant. Nevertheless Although the mechanism of the atorvastatin-associated infertility observed in the present study may involve impairment of sperm storage, oviductal transport and sperm-egg binding, it is hypothesized that defective spermegg binding alone may explain this observation. This is supported by a number of observations. Firstly, both O-and N-linked oligosaccharides are known to play a role in avian sperm-egg binding (Howarth, 1992) . In addition, chicken zona pellucida glycoprotein C, a perivitelline membrane protein and the chicken homologue of the mammalian sperm receptor (zona pellucida glycoprotein 3), is N-glycosylated (Waclawek et ah, 1998) . Dolichol, a mevalonate-derived product, functions (via dolichyl-phosphate) as an oligosaccharide carrier in the assembly of the carbohydrate chains of JV-linked glycoproteins (Kornfeld and Kornfeld, 1985) . Finally, the cellular depletion of mevalonate decreases both the synthesis of dolichyl-phosphate and the rate of N-linked glycosylation in cultured human melanoma cells (Carlberg et ah, 1996) . Therefore, it is speculated that the marked decrease in fertility in laying hens fed 0.06% atorvastatin may be due to a decrease in N-glycosylation of chicken zona pellucida glycoprotein C, which results in impaired sperm-egg binding. Studies are currently underway to address this possibility.
